Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study.
Farolfi A, Scarpi E, Greco F, Bergamini A, Longo L, Pignata S, Casanova C, Cormio G, Bologna A, Orditura M, Zavallone L, Attademo L, Gallà V, Franzese E, Pigozzi E, Loizzi V, Giorda G, Giardina D, Cioffi R, De Giorgi U. Farolfi A, et al. Among authors: cioffi r. Sci Rep. 2020 Oct 23;10(1):18190. doi: 10.1038/s41598-020-75316-x. Sci Rep. 2020. PMID: 33097745 Free PMC article.
Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer.
Bergamini A, Ferrero S, Leone Roberti Maggiore U, Scala C, Pella F, Vellone VG, Petrone M, Rabaiotti E, Cioffi R, Candiani M, Mangili G. Bergamini A, et al. Among authors: cioffi r. Expert Opin Investig Drugs. 2016 Dec;25(12):1405-1412. doi: 10.1080/13543784.2016.1254616. Expert Opin Investig Drugs. 2016. PMID: 27797594 Review.
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24).
Farolfi A, Petrone M, Scarpi E, Gallà V, Greco F, Casanova C, Longo L, Cormio G, Orditura M, Bologna A, Zavallone L, Ventriglia J, Franzese E, Loizzi V, Giardina D, Pigozzi E, Cioffi R, Pignata S, Giorda G, De Giorgi U. Farolfi A, et al. Among authors: cioffi r. Target Oncol. 2018 Aug;13(4):469-479. doi: 10.1007/s11523-018-0574-1. Target Oncol. 2018. PMID: 29948780
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study.
Mangili G, Cioffi R, Danese S, Frigerio L, Ferrandina G, Cormio G, Rabaiotti E, Scarfone G, Gadducci A, Bergamini A, Pisano C, Candiani M. Mangili G, et al. Among authors: cioffi r. Gynecol Oncol. 2018 Dec;151(3):449-452. doi: 10.1016/j.ygyno.2018.09.025. Epub 2018 Sep 26. Gynecol Oncol. 2018. PMID: 30266260
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer.
Mapelli P, Bergamini A, Fallanca F, Rancoita PMV, Cioffi R, Incerti E, Rabaiotti E, Petrone M, Mangili G, Candiani M, Gianolli L, Picchio M. Mapelli P, et al. Among authors: cioffi r. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Jan-Feb;38(1):3-9. doi: 10.1016/j.remn.2018.06.007. Epub 2018 Dec 17. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019. PMID: 30573387 English, Spanish.
A Pictorial Ultrasound Essay of Gestational Trophoblastic Disease.
Cavoretto P, Cioffi R, Mangili G, Petrone M, Bergamini A, Rabaiotti E, Valsecchi L, Candiani M, Seckl MJ. Cavoretto P, et al. Among authors: cioffi r. J Ultrasound Med. 2020 Mar;39(3):597-613. doi: 10.1002/jum.15119. Epub 2019 Aug 29. J Ultrasound Med. 2020. PMID: 31468566 Review.
142 results